Prostate cancer: On the road of progress

Michel Bolla^{1

2}, René-Olivier Mirimanoff²

Affiliations

Editorial

Michel Bolla et al. Asian J Urol. 2019 Apr.

. 2019 Apr;6(2):123-124.

doi: 10.1016/j.ajur.2019.01.002. Epub 2019 Jan 9.

Michel Bolla^{1

2}, René-Olivier Mirimanoff²

No abstract available

References

1. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H. Cancer incidence and mortality patterns in Europe : estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403. - PubMed
1. Chen W., Zheng R., Zeng H., Zhang S. The updated incidences and mortalities of major cancer in China, 2011. Chin J Cancer. 2015;34:502–507. - PMC - PubMed
1. Hankey B.F., Feuer E.J., Clegg L.X., Hayes R.B., Legler J.M., Prorok P.C. Cancer surveillance series : interpreting trends in prostate cancer-part I : evidence of the effects of screening in recent prostate incidence. J Natl Cancer Inst. 1999;91:1017–1024. - PubMed
1. Mottet N, Bellmunt J, Briers and members of the EAU-ESTRO-ESUR-SIOG. Guidelines panel on Prostate Cancer. [accessed 26 December 2018]. http://uroweb.org/guideline/prostate-cancer/.
1. Bolla M., van Poppel H. 2nd ed. Springer; Switzerland: 2017. Management of prostate cancer. A multidisciplinary approach; pp. 1–141.